A critical advance in cancer research is emerging with the use of nanobodies to re-engage damaged p53. This crucial cancer inhibitor protein is frequently inactivated in various kinds of tumors, resulting uncontrolled https://worldsocialindex.com/story7055665/nanobodies-revive-the-p53-protein-new-potential-approach-for-malignant-management